FDA.reportPublic FDA data

RITONAVIR

Substance profile for UNII O3J8G9O825, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for RITONAVIR
Structure render from PubChem CID 392622

Substance Identity#

UNII
O3J8G9O825
Preferred term
RITONAVIR
Registry number
155213-67-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C37H48N6O5S2
Chemical structure for RITONAVIR
Structure render from PubChem CID 392622

Chemical And Database Identifiers#

InChIKey
NCDNCNXCDXHOMX-XGKFQTDJSA-N
SMILES
CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
RxCUI
85762
PubChem
392622
NCIt
C1609
INN ID
7449

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound392622https://pubchem.ncbi.nlm.nih.gov/compound/392622
PubChem InChIKey SearchNCDNCNXCDXHOMX-XGKFQTDJSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=NCDNCNXCDXHOMX-XGKFQTDJSA-N
RxNorm85762https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=85762
NCI ThesaurusC1609https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1609
FDA Substance Registration SystemO3J8G9O825https://precision.fda.gov/uniisearch/srs/unii/O3J8G9O825

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
RITONAVIRACTIVE INGREDIENTO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RITONAVIRACTIVE MOIETYO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RITONAVIRACTIVE INGREDIENTO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RITONAVIRACTIVE MOIETYO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RITONAVIRACTIVE MOIETYO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
RITONAVIRACTIVE INGREDIENTO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
RitonavirACTIVE MOIETYO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RitonavirACTIVE INGREDIENTO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RITONAVIRACTIVE INGREDIENTO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RITONAVIRACTIVE MOIETYO3J8G9O825These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
RITONAVIRACTIVE MOIETYO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
RITONAVIRACTIVE INGREDIENTO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
RITONAVIRACTIVE INGREDIENTO3J8G9O825NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
RITONAVIRACTIVE MOIETYO3J8G9O825NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
RITONAVIRACTIVE INGREDIENTO3J8G9O825NORVIR (RITONAVIR) CAPSULE [ABBVIE INC.]1503
RITONAVIRACTIVE MOIETYO3J8G9O825NORVIR (RITONAVIR) CAPSULE [ABBVIE INC.]1503
RITONAVIRACTIVE INGREDIENTO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
RITONAVIRACTIVE MOIETYO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
RITONAVIRACTIVE MOIETYO3J8G9O825VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]203
RITONAVIRACTIVE INGREDIENTO3J8G9O825VIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]203
RITONAVIRACTIVE INGREDIENTO3J8G9O825TECHNIVIE (OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]53
RITONAVIRACTIVE MOIETYO3J8G9O825TECHNIVIE (OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]53
RITONAVIRACTIVE INGREDIENTO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH]4
RITONAVIRACTIVE MOIETYO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [CARDINAL HEALTH]4
RITONAVIRACTIVE INGREDIENTO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
RITONAVIRACTIVE MOIETYO3J8G9O825KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]1
RITONAVIRACTIVE INGREDIENTO3J8G9O825NORVIR (RITONAVIR) TABLET, FILM COATED [REMEDYREPACK INC. ]1
RITONAVIRACTIVE MOIETYO3J8G9O825NORVIR (RITONAVIR) TABLET, FILM COATED [REMEDYREPACK INC. ]1